Skip to main content

Teva Pharmaceuticals USA

Recalls

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
201812
20196
202022
202153
20227
Download CSV

FDA Recall Terminated Historical recordClass II

Alprostadil Injection USP, 500 mg/mL, 1 mL single dose, vials, 5 mL single use vial per carton (NDC 0703-1501-02), Rx only, Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, Vial NDC 0703-1501-01

by Teva Pharmaceuticals USA

Reason
Lack of Assurance of Sterility
Published
August 25, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Metoclopramide Injection USP, 10 mg/2mL (5 mg/mL) 2 mL single-use vial, Rx only, Teva Parenteral Medicines, Inc. Irvine, CA 92618, NDC 0703-4502-01

by Teva Pharmaceuticals USA

Reason
Lack of Assurance of Sterility
Published
August 25, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Adenosine Injection, USP, 60mg/20mL (3 mg/mL), 20 mL single-dose vial, Rx only, Manufactured by: Teva Pharmaceuticals USA Inc. Parsippany, NJ 07054, NDC 0703-8776-01

by Teva Pharmaceuticals USA

Reason
Lack of Assurance of Sterility
Published
August 25, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Norepinephrine Bitartrate Injection, USP 4 mg/4 mL, 4 mL single dose vials, packaged in 10 vial cartons (NDC 0703-1153-03) Rx only, Teva Pharmaceuticals USA Inc. North Wales, PA 19454, vial NDC 0703-1153-01

by Teva Pharmaceuticals USA

Reason
Lack of Assurance of Sterility
Published
August 25, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Epoprostenol Sodium for Injection, 1.5 mg/vial, 10 mL vials, Rx only, Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0703-1995-01

by Teva Pharmaceuticals USA

Reason
Lack of Assurance of Sterility
Published
August 25, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Leucovorin Calcium for Injection, USP 350 mg/vial, 17.5 mL single-use vials, Rx only, Teva Parenteral Medicines, Inc. Irvine, CA 92618, NDC 0703-5145-01

by Teva Pharmaceuticals USA

Reason
Lack of Assurance of Sterility
Published
August 25, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Octreotide Acetate Injection 1000 mcg/5mL, 5 mL multi-dose vial, Rx only, Teva Pharmaceuticals USA. Inc. North Wales, PA 19454, NDC 0703-3333-01

by Teva Pharmaceuticals USA

Reason
Lack of Assurance of Sterility
Published
August 25, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Vecuronium Bromide for Injection 10 mg, 10mL vial, Rx only, Teva Pharmaceuticals USA, North Wales, PA 19454, NDC 0703-2914-01

by Teva Pharmaceuticals USA

Reason
Lack of Assurance of Sterility
Published
August 25, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Idarubicin Hydrochloride Injection 20 mg/20 mL, 20 mL single-dose vial, Rx only, Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0703-4156-11

by Teva Pharmaceuticals USA

Reason
Lack of Assurance of Sterility
Published
August 25, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Amikacin Sulfate Injection USP 1 gram/4mL (250mg/ML), 4 mL single-dose vials, Rx only, Teva Pharmaceuticals USA Inc. North Wales, PA 19454, NDC 0703-9040-01

by Teva Pharmaceuticals USA

Reason
Lack of Assurance of Sterility
Published
August 25, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Haloperidol Decanoate Injection 100 mg/mL, packaged in a) 1 mL single-dose vials (NDC 0703-7131-01), b) 5 mL multi-dose vials (NDC 0703-7133-01), Rx only, Teva Pharmaceuticals USA, Inc. North Wales, PA 19454.

by Teva Pharmaceuticals USA

Reason
Lack of Assurance of Sterility
Published
August 25, 2021
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Methylprednisolone Acetate Injectable Suspension USP, 40 mg/mL, packaged in a) 1 mL Single-Dose vials (0703-0031-01), and b) 5mL Multi Dose Vials (NDC 0703-0043-01), and c) 10 mL Multi-Dose Vials (NDC 0703-0045-01), Rx only, TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454.

by Teva Pharmaceuticals USA

Reason
Lack of Assurance of Sterility
Published
August 25, 2021
Distribution
Nationwide

View recall →

This page lists recalls that name Teva Pharmaceuticals USA as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.